© 2002 by Annals of the Rheumatic Diseases
REPORT
Type II collagen degradation and its regulation in articular cartilage in osteoarthritis
1 Shriners Hospitals for Children, Departments of Surgery and Medicine, McGill University, Montreal, Quebec, Canada
2 Department of Orthopaedic Surgery, Kyoto University Medical School, Kyoto, Japan
3 Faculty of Veterinary Medicine, Department of Clinical Sciences, University of Montreal, Ste-Hyacinthe, Quebec, Canada
4 Department of Orthopaedic Surgery, Jewish General Hospital, Montreal, Quebec, Canada
5 Department of Orthopaedic Surgery, Nagoya University School of Medicine, Nagoya, Japan
6 Molecular Cell Biology Unit, Glaxo Wellcome Research, Stevenage, Hertfordshire, UK
7 Arthritis Unit, Massachusetts General Hospital, Boston, MA, USA
Correspondence to:
Correspondence to:
Dr A R Poole;
rpoole@shriners.mcgill.ca
Keywords: collagen; articular cartilage; osteoarthritis
Abbreviations: IL, interleukin; JSN, joint space narrowing; MMP, matrix metalloproteinase; OA, osteoarthritis; RA, rheumatoid arthritis, TGFß, transforming growth factor ß; TNF, tumour necrosis factor
| The first 150 words of the full text of this article appear below. |
The progressive degeneration of articular cartilage is an underlying problem in the pathogenesis of osteoarthritis (OA) as well as in rheumatoid arthritis (RA) and other inflammation arthritides. It leads to a loss of joint function, frequently accompanied by debilitating pain.
In idiopathic OA this is a degenerative process that may cover a period of 2030 years, culminating in clinical presentation and a need for joint replacement as the only effective means of managing this condition. There are as yet no recognisable disease modifying treatments for OA; only symptomatic treatment (pain relief) is possible.
The physical and economic burden of OA is enormous, affecting up to 15% of the total population (>50% of the aging population over 60 years of age). We face an enormous challenge in the management of this condition. Yet with recent progress in reaching an improved understanding of the pathobiology of this condition there is a realisation
This article has been cited by other articles:
-
DONG, W., ZHANG, Y., LIU, H., GAO, B., LI, D., YANG, J.
(2009). Detection of Unsaturated Disaccharides, Pyridinoline, and Hydroxyproline in Urine of Patients with Kashin-Beck Disease: Comparison with Controls in an Endemic Area. The Journal of Rheumatology
36: 816-821
[Abstract] [Full Text] -
Zhang, Q, Hui, W, Litherland, G J, Barter, M J, Davidson, R, Darrah, C, Donell, S T, Clark, I M, Cawston, T E, Robinson, J H, Rowan, A D, Young, D A
(2008). Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis
67: 1633-1641
[Abstract] [Full Text] -
Meulenbelt, I, Kloppenburg, M, Kroon, H M, Houwing-Duistermaat, J J, Garnero, P, Hellio Le Graverand, M-P, DeGroot, J, Slagboom, P E
(2006). Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann Rheum Dis
65: 360-365
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
